Transfection of a murine fibrosarcoma with intercellular adhesion molecule-1 enhances the response to adoptive immunotherapy

Surgery

Volumn 118, Issue 2, 1995, Pages 237-244

  Burno, Derrick K ^a   Kyprianou, Natasha ^a   Sartor, Walter M ^a   Fabian, Dagmar F ^a   Joel, Turner ^a   Wu, Tuananh ^a   Patel, Amitabh ^a   Trimbach, Craig ^a   Lefor, Alan T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIBROSARCOMA; GENETIC TRANSFECTION; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMAL; CELL DIVISION; DRUG RESISTANCE, MICROBIAL; FEMALE; FIBROSARCOMA; HYPERTHERMIA, INDUCED; IMMUNOTHERAPY, ADOPTIVE; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, LYMPHOKINE-ACTIVATED; MICE; NEOMYCIN; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029116897     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(05)80329-0     Document Type: Article

References (21)

1. Combined modality therapy for murine subcutaneous tumors with immunotherapy and hyperthermia
2. The effects of hyperthermia on vascular permeability in experimental liver metastases
3. Immunotherapy and whole-body hyperthermia as combined modality treatment of a subcutaneous murine sarcoma
4. Local hyperthermia abrogates the antiimmunotherapeutic effect of Interleukin-8
5. Hyperthermia increases intercellular adhesion molecule—1 expression and lymphocyte adhesion to endothelial cells
6. Sartor W, Kyprianou N, Fabian DF, Lefor AT. Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor growth rate. J Surg Res (in press).
7. Analysis of chromium-51 release assay data using personal computer spreadsheet software
8. In vivo induction of the lymphokine-activated killer phenomenon: interleukin-2 dependent human non major histocompatibility complex restricted cytotoxicity generated in vivo during administration of human recombinant interleukin-2
9. Tumor suppressive role of an androgen regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches
10. Increased susceptibility of IFNγtreated neuroblastoma cells to lysis by lymphokine activated killer cells participation of ICAM-1 induction on target cells
11. Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes
12. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells
13. Circulating intercellular adhesion molecule—1 in melanoma patients: induction by Interleukin-2 therapy
14. Up-regulation of adhesion molecules by immunotherapy as a mechanism of cytotoxicity in renal cell cancer, malignant melanoma, and acute myelocytic leukemia
15. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor mediated activation of resting T cells
16. ICAM-melanoma cells are relatively resistant to CD3-mediated T-cell lysis
17. Murine tumor cells transfected with the gene for tumor necrosis factora evidence for paracrine immune effects of tumor necrosis factor against tumors
18. The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified
19. Isolation, characterization and expression of mouse ICAM-2 complimentary and genomic DNA
20. On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules
21. High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma